Dhar and colleagues reported that expression of CCND1 was up-regulated in about 90% of patients with EOC and expressed mainly in both borderline and invasive tumours without any association between immunoreactive protein overexpression and stage of tumor differentiation or grade of tumor [20]. Here, CCND1 is linked to neoplasm.